A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder
Timothy E. Wilens(Massachusetts General Hospital), Andrew J. Cutler(Meridien Research), Linda Harper(CNS Healthcare), Vanja Sikirica(Moderna Therapeutics (United States)), A. G. Lyne(University of Manchester), Joel Young(Wayne State University), Ralph Bloomfield(Takeda (United States)), Brigitte Robertson(Takeda (United States)), Gail Rynkowski(Takeda (United States))
Journal of the American Academy of Child & Adolescent Psychiatry
September 15, 2015
Cited by 63
Related Papers
Tests of General Relativity from Timing the Double Pulsar
|Science|2006|1.1k
Impact of Executive Function Deficits and Attention-Deficit/Hyperactivity Disorder (ADHD) on Academic Outcomes in Children.
|Journal of Consulting and Clinical Psychology|2004|882
Does Stimulant Therapy of Attention-Deficit/Hyperactivity Disorder Beget Later Substance Abuse? A Meta-analytic Review of the Literature
|PEDIATRICS|2003|868
Influence of Gender on Attention Deficit Hyperactivity Disorder in Children Referred to a Psychiatric Clinic
|American Journal of Psychiatry|2002|862
Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study
|Psychological Medicine|2006|851